ENvue Medical, Inc. (NASDAQ:FEED) on Wednesday said it launched a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.

"With the launch of our over-the-counter ENFit Syringes, available in institutional and consumer-friendly packaging, we are expanding access to safe, affordable, and standardized enteral delivery tools…," said Doron Besser, CEO of ENvue Medical.

ENvue's Syringe Launch

ENvue's ENFit Syringes are currently anticipated to be available at certain online retailers, including Amazon and Durable Medical Equipment suppliers, in 2.5 mL, 5 mL, 10 mL, and 60 mL sizes, without the need for a prescription.

The ENFit syringes are designed for reuse for up to seven days or 20 uses, helping support safe and consistent enteral delivery in both clinical and home care environments.

Background

In December 2025, NanoVibronix Inc. changed its corporate name to ENvue Medical to better reflect its new strategic direction and primary focus on its ENvue feeding-tube placement system.

Last week, ENvue Medical launched a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric tubes.

Nasogastric tubes are among the most widely used devices in hospital care and are frequently required to remain in place for extended periods. While clinically essential, indwelling NG tubes are commonly associated with nasal and throat discomfort during the dwell phase.

FEED Price Action: ENvue Medical shares were down 2.16% at $2.27 during premarket trading on Wednesday, according to Benzinga Pro data.